These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2338629

  • 1. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
    Venkataram S, Awni WM, Jordan K, Rahman YE.
    J Pharm Sci; 1990 Mar; 79(3):216-9. PubMed ID: 2338629
    [Abstract] [Full Text] [Related]

  • 2. Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.
    Gruber SA, Venkataram S, Canafax DM, Cipolle RJ, Bowers L, Elsberry D, McGuiggan M, Hynes PE, Ritz JA, Gould FH.
    Pharm Res; 1989 Jul; 6(7):601-7. PubMed ID: 2798309
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles.
    Lee MK, Choi L, Kim MH, Kim CK.
    Int J Pharm; 1999 Nov 30; 191(2):87-93. PubMed ID: 10564835
    [Abstract] [Full Text] [Related]

  • 4. Effect of co-administration of Intralipid on the pharmacokinetics of cyclosporine in the rabbit.
    Shah AK, Sawchuk RJ.
    Biopharm Drug Dispos; 1991 Nov 30; 12(6):457-66. PubMed ID: 1932609
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M, Bindschedler M, Costa E, Zuber M, Vozeh S, Thiel G, Abisch E, Keller HP, Beveridge T, Follath F.
    Transplantation; 1988 Mar 30; 45(3):558-61. PubMed ID: 3347936
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine-phenytoin interaction.
    D'Souza MJ, Pollock SH, Solomon HM.
    Drug Metab Dispos; 1988 Mar 30; 16(2):256-8. PubMed ID: 2898343
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.
    Smeesters C, Giroux L, Vinet B, Arnoux R, Chaland P, Corman J, St-Louis G, Daloze P.
    Can J Surg; 1988 Jan 30; 31(1):34-6. PubMed ID: 3257403
    [Abstract] [Full Text] [Related]

  • 8. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
    Guada M, Sebastián V, Irusta S, Feijoó E, Dios-Viéitez Mdel C, Blanco-Prieto MJ.
    Int J Nanomedicine; 2015 Jan 30; 10():6541-53. PubMed ID: 26527872
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine-cimetidine interaction.
    D'Souza MJ, Pollock SH, Solomon HM.
    Drug Metab Dispos; 1988 Jan 30; 16(1):57-9. PubMed ID: 2894956
    [Abstract] [Full Text] [Related]

  • 10. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
    Lo YL, Liu FI, Yang JM, Cherng JY.
    Anticancer Res; 2001 Jan 30; 21(1A):445-50. PubMed ID: 11299776
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats.
    Koehn S, Frey FJ, Speck RF, Zeugin T, Schaffner T, Zimmermann A, Frey BM.
    J Pharmacokinet Biopharm; 1990 Oct 30; 18(5):381-99. PubMed ID: 2266495
    [Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive effect of cyclosporin A incapsulated into liposomes].
    Arnoux R, Dufourcq J, Smeesters C, Lalanne J, Deminière C, Penin E, Clerc M, Poteaux L, Dartigues JF, Michel A.
    Chirurgie; 1990 Oct 30; 116(8-9):699-703. PubMed ID: 2129987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine A lipid nanoparticles for oral administration: Pharmacodynamics and safety evaluation.
    Guada M, Lana H, Gil AG, Dios-Viéitez Mdel C, Blanco-Prieto MJ.
    Eur J Pharm Biopharm; 2016 Apr 30; 101():112-8. PubMed ID: 26877154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
    Aliabadi HM, Brocks DR, Lavasanifar A.
    Biomaterials; 2005 Dec 30; 26(35):7251-9. PubMed ID: 16005061
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
    Pollock SH, Matthews HW, D'Souza MJ.
    Drug Metab Dispos; 1989 Dec 30; 17(6):595-9. PubMed ID: 2575493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.